A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome.
作者信息
LeBlanc Francis R, Grier David D, Myers Kasiani C, Shimamura Akiko, Pommert Lauren
机构信息
Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
出版信息
Pediatr Blood Cancer. 2024 Aug;71(8):e31137. doi: 10.1002/pbc.31137. Epub 2024 Jun 4.
Abstract
摘要
相似文献
1
A case of co-occurring acute myeloid leukemia and relapsed diffuse large B-cell lymphoma in a young adult with Shwachman-Diamond syndrome.
Pediatr Blood Cancer. 2024 Aug;71(8):e31137. doi: 10.1002/pbc.31137. Epub 2024 Jun 4.
2
Diffuse alterations in grey and white matter associated with cognitive impairment in Shwachman-Diamond syndrome: evidence from a multimodal approach.
Neuroimage Clin. 2015 Feb 27;7:721-31. doi: 10.1016/j.nicl.2015.02.014. eCollection 2015.
3
Ubiquitin-proteasome-rich cytoplasmic structures in neutrophils of patients with Shwachman-Diamond syndrome.
Haematologica. 2012 Jul;97(7):1057-63. doi: 10.3324/haematol.2011.048462. Epub 2012 Jan 22.
4
Dysplastic neutrophils in the bone marrow of a Shwachman-Diamond syndrome patient.
Blood. 2017 Jul 6;130(1):96. doi: 10.1182/blood-2017-03-773846.
5
Young-age-onset pancreatoduodenal carcinoma in Shwachman-Diamond syndrome.
Pathol Int. 2014 Feb;64(2):75-80. doi: 10.1111/pin.12133.
6
Translational medicine: ribosomopathies.
Blood. 2011 Oct 20;118(16):4300-1. doi: 10.1182/blood-2011-08-372250.
7
Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond Syndrome.
Hematol Oncol Clin North Am. 2018 Aug;32(4):687-700. doi: 10.1016/j.hoc.2018.04.006. Epub 2018 Jun 5.
8
CNS lymphoma in a patient with Shwachman Diamond syndrome.
Pediatr Blood Cancer. 2014 Mar;61(3):564-6. doi: 10.1002/pbc.24743. Epub 2013 Nov 8.
9
Absence of acquired copy number neutral loss of heterozygosity (CN-LOH) of chromosome 7 in a series of 10 patients with Shwachman-Diamond syndrome.
Br J Haematol. 2014 May;165(4):573-5. doi: 10.1111/bjh.12767. Epub 2014 Feb 1.
10
The Greek Registry of Shwachman Diamond-Syndrome: Molecular and clinical data.
Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26630. Epub 2017 May 16.
引用本文的文献
1
Lymphoid malignancies in patients with Shwachman-Diamond syndrome.
Blood. 2025 May 22;145(21):2528-2532. doi: 10.1182/blood.2024026507.
本文引用的文献
1
Venetoclax for Acute Myeloid Leukemia in Pediatric Patients: A Texas Medical Center Experience.
Cancers (Basel). 2023 Mar 26;15(7):1983. doi: 10.3390/cancers15071983.
2
Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax.
Haematologica. 2023 Nov 1;108(11):3142-3147. doi: 10.3324/haematol.2022.282637.
3
Hematologic complications with age in Shwachman-Diamond syndrome.
Blood Adv. 2022 Jan 11;6(1):297-306. doi: 10.1182/bloodadvances.2021005539.
4
Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.
Lancet Haematol. 2021 Aug;8(8):e552-e561. doi: 10.1016/S2352-3026(21)00192-7.
5
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma.
Blood. 2021 Feb 4;137(5):600-609. doi: 10.1182/blood.2020006578.
6
An update of venetoclax and obinutuzumab in chronic lymphocytic leukemia.
Future Oncol. 2021 Feb;17(4):371-387. doi: 10.2217/fon-2020-0640. Epub 2020 Oct 16.
7
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia.
N Engl J Med. 2020 Aug 13;383(7):617-629. doi: 10.1056/NEJMoa2012971.
8
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
Lancet Haematol. 2020 Mar;7(3):e238-e246. doi: 10.1016/S2352-3026(19)30206-6. Epub 2019 Dec 23.
9
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.
Br J Haematol. 2020 Feb;188(3):e11-e15. doi: 10.1111/bjh.16268. Epub 2019 Nov 4.
10
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.
N Engl J Med. 2019 Jun 6;380(23):2225-2236. doi: 10.1056/NEJMoa1815281. Epub 2019 Jun 4.
Zotero 插件